Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 3/20 | 0.39 |
| ▸ | GNAO1 | P09471 | 3/20 | 0.39 |
| ▸ | GNAI1 | P63096 | 3/20 | 0.39 |
| ▸ | PRCP | P42785 | 2/20 | 0.33 |
| ▸ | GBA1 | P04062 | 7/20 | 0.33 |
| ▸ | FUCA1 | P04066 | 6/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9152652 | 0.97 | GNAI3 (0.41) | GNAI3GNAO1GNAI1PRCPGBA1 | |
| Hydrazine SCHEMBL8557568 | 0.88 | — | — | |
| SCHEMBL2122691 | 0.84 | — | — | |
| SCHEMBL11302086 | 0.71 | GNAI3 (0.53) | GNAI3GNAO1GNAI1PRCPGBA1 | |
| Hexane SCHEMBL27946483 | 0.71 | ALDH1A1 (0.35) | PRCPGBA1 | |
| SCHEMBL10906234 | 0.70 | PRCP (0.49) | GNAI3GNAO1GNAI1PRCPGBA1 | |
| SCHEMBL7505210 | 0.70 | GNAI3 (0.46) | GNAI3GNAO1GNAI1PRCP | |
| SCHEMBL7042804 | 0.70 | GNAI3 (0.56) | GNAI3GNAO1GNAI1PRCPGBA1 | |
| SCHEMBL7041937 | 0.70 | GNAI3 (0.56) | GNAI3GNAO1GNAI1PRCPGBA1 | |
| SCHEMBL10945126 | 0.69 | GNAI3 (0.51) | GNAI3GNAO1GNAI1PRCPGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0575954-B1 | Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process | MEDIOLANUM FARMACEUTICI SRL (IT) | 1998-09-02 | — | — | EP | disclosed |